As most women get older, and especially after menopause, the milk-producing glands (lobules) shut down -- a process known as lobular regression, or involution. Since breast cancer is thought to originate in the lobules, their reduced size and number decreases the chance of cancer formation. Women who experience complete involution have half the risk of developing breast cancer of those who do not.
"The risk of breast cancer increases among women who have no breast involution as they age," says Lynn Hartmann, M.D., Mayo Clinic oncologist and lead investigator of the study. "This study identifies specific groups of women who are at lower or higher risks of breast cancer due to their extent of involution and factors such as age, family cancer history, reproductive history and types of benign breast disease."Breast cancer is a significant threat to women. The American Cancer Society reports that more than 250,000 women will be diagnosed in the United States this year with breast cancer, and at least 40,000 will die from it. Dr. Hartmann's team is working to better understand the steps that precede breast cancer and which of them can be recognized in benign breast tissue. In a previous study, published in the New England Journal of Medicine (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16034008&query_
hl=3&itool=pubmed_docsum) in 2005, they showed that certain types of benign breast disease increase the risk of breast cancer.
The current study contributes to Mayo's emerging model that seeks to define individual women's risk more precisely and thus be able to tailor screening and risk-reducing measures to women depending on their individual risks.
The investigators found that among women with benign breast disease and little or no breast tissue involution, risk for developing breast cancer was twice that of women whose breast glandular tissues had been replaced completely with connective and fatty tissue (53 percent had complete involution as they aged beyond 70 years).
The study included 8,736 women who had breast biopsies at Mayo Clinic that were benign during a 25-year period starting in 1967. Breast tissue samples from this Mayo Clinic Benign Breast Disease cohort were evaluated to determine extent of involution. As a group, the Mayo cohort was at 40 percent increased risk of breast cancer compared to a larger population of presumably healthy women who comprise the Iowa Surveillance, Epidemiology and End Results (SEER) registry. This increased risk has been seen in other cohorts of women with benign breast tissue. However, those in the Mayo cohort who had complete breast lobular involution had no more risk of developing breast cancer than the baseline established in the Iowa SEER cohort.
The researchers found that hormone replacement therapy and prior pregnancies play a role in progression of involution. Hormonal replacement therapy had a slight impact on amount of involution. More women (22.9 percent) who never took hormone replacement had complete involution of mammary tissue than women (20.3 percent) who were treated with estrogen, progesterone or combinations of these two female hormones. Women who gave birth to more than three children retained a greater number of breast lobules. More women (27 percent) who had no children had complete involution, while only 18 percent of women with four children completed mammary involution. Breast-feeding of children had no impact on extent of involution.
"The research community has not focused on breast involution in recent years, nor has this natural process previously been linked to breast cancer risk," reports Dr. Hartmann. "Our study is the first to establish that the extent of breast involution relates directly to risk for breast cancer." She also says that women who would otherwise be considered at high risk (such as those with atypia) appear to have reduced risk when greater degrees of involution are present.
By documenting involution status in a woman's background breast tissue, cancer physicians have another important variable to aid in predicting a woman's risk, at least in women with benign breast tissue. This information can be considered with epidemiological background, individual factors such as age and reproductive history. Ultimately, it is hoped that biomarkers will be defined that contribute to the risk of breast cancer, and these will be integrated into a comprehensive Mayo model for breast cancer risk assessment.
Dr. Hartmann added that by appraising an individual's personal information within a complete, integrated model for predicting risk, every woman's breast cancer risk can be determined with precision and accuracy, leading to the patient's optimal peace of mind based on accurate risk assessment and the appropriate level of preventive intercession and awareness.
Study relating to materials testing Detecting damages in non-magnetic steel through magnetism
23.07.2018 | Technische Universität Kaiserslautern
Innovative genetic tests for children with developmental disorders and epilepsy
11.07.2018 | Christian-Albrechts-Universität zu Kiel
New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference
Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
17.08.2018 | Event News
08.08.2018 | Event News
27.07.2018 | Event News
17.08.2018 | Physics and Astronomy
17.08.2018 | Information Technology
17.08.2018 | Life Sciences